ConductScience.org, home

Paper7608697

Dose standardisation of botulinum toxin.

Marion MH and 3 others. J Neurol Neurosurg Psychiatry, 1995. Cited by 70 papers, by iCite.

Cite this record

ConductScience Library. Dose standardisation of botulinum toxin. Papers, record 7608697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7608697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dose standardisation of botulinum toxin.
PubMed
Journal
J Neurol Neurosurg Psychiatry
PubMed
Year
1995
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Letter
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
3.54
iCite
Revised in PubMed
2019-05-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marion MHM H
2Sheehy MM
3Sangla SS
4Soulayrol SS

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BlepharospasmMajor topic
Botulinum ToxinsMajor topic
Facial ParalysisMajor topic
Adult
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Therapeutic Equivalency

Source PubMed

Download CSV of topics

References5

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17837204Potency equivalence of botulinum toxin preparations.J R Soc Med1994https://conductscience.org/library/papers/7837204PubMed
22565459Dose standardisation of botulinum toxin.Lancet1989https://conductscience.org/library/papers/2565459PubMed
38078064Botulinum toxin: dangerous terminology errors.J R Soc Med1993https://conductscience.org/library/papers/8078064PubMed
47914582Dose standardisation of botulinum toxin.Lancet1994https://conductscience.org/library/papers/7914582PubMed
51968156Dose standardisation of botulinum toxin.Lancet1990https://conductscience.org/library/papers/1968156PubMed

Download CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
40137876Switox: Retrospective Analysis of Botulinum Toxin Switching in Management of Spasticity.Toxins (Basel)2025https://conductscience.org/library/papers/40137876PubMed
38922160Update on Non-Interchangeability of Botulinum Neurotoxin Products.Toxins (Basel)2024https://conductscience.org/library/papers/38922160PubMed
38312815Long-term follow-up of intravesical abobotulinumtoxinA (Dysport®) injections in women with idiopathic detrusor overactivity.Asian J Urol2024https://conductscience.org/library/papers/38312815PubMed
34941718Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies.Toxins (Basel)2021https://conductscience.org/library/papers/34941718PubMed
33057730A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus.J Rehabil Med2021https://conductscience.org/library/papers/33057730PubMed
32886157Clinical Pharmacology of Botulinum Toxin Drugs.Handb Exp Pharmacol2021https://conductscience.org/library/papers/32886157PubMed
32270340Use of Botulinum Toxin in Ophthalmology.Handb Exp Pharmacol2021https://conductscience.org/library/papers/32270340PubMed
31707463Comparing lanbotulinumtoxinA (Hengli®) with onabotulinumtoxinA (Botox®) and incobotulinumtoxinA (Xeomin®) in the mouse hemidiaphragm assay.J Neural Transm (Vienna)2019https://conductscience.org/library/papers/31707463PubMed
30209743Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment.Clin Drug Investig2018https://conductscience.org/library/papers/30209743PubMed
29946929Comparing incobotulinumtoxinA (Xeomin®) and onabotulinumtoxinA (Botox®): identical potency labelling in the hemidiaphragm assay.J Neural Transm (Vienna)2018https://conductscience.org/library/papers/29946929PubMed
29633692Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.Funct Neurol2018https://conductscience.org/library/papers/29633692PubMed
26959061Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice.Toxins (Basel)2016https://conductscience.org/library/papers/26959061PubMed
21971766Measuring the potency labelling of onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin (®)) in an LD50 assay.J Neural Transm (Vienna)2012https://conductscience.org/library/papers/21971766PubMed
21710123Retrospective evaluation of the dose equivalence of Botox(®) and Dysport (®) in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story.Neurol Sci2012https://conductscience.org/library/papers/21710123PubMed
20418969Botulinum toxin.Indian J Dermatol2010https://conductscience.org/library/papers/20418969PubMed
19352590Prevalence of neutralising antibodies in patients treated with botulinum toxin type A for spasticity.J Neural Transm (Vienna)2009https://conductscience.org/library/papers/19352590PubMed
14745647Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review.Dysphagia2004https://conductscience.org/library/papers/14745647PubMed
11909903Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.J Neurol Neurosurg Psychiatry2002https://conductscience.org/library/papers/11909903PubMed
9875028Position paper on the use of botulinum toxin in cerebral palsy. UK Botulinum Toxin and Cerebral Palsy Working Party.Arch Dis Child1998https://conductscience.org/library/papers/9875028PubMed
9436720A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia.J Neurol Neurosurg Psychiatry1998https://conductscience.org/library/papers/9436720PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7608697

GET https://conductscience.org/api/papers/v1/7608697/cited_by?page=2